PU

Pradyumna Upendra Pande

Active Director Director DIN 06876992
DIN 06876992 First appointment May 2014 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since May 2014
Shareholding value β€’β€’β€’β€’ Premium profile

About Pradyumna Upendra Pande

Data last updated:

Pradyumna Upendra Pande is a Director at Eye Kare Kilitch Limited (since 2014). The company operates in Pharma.

DIN 06876992
Primary Designation Director
Industry Pharma
First Appointment 27 May 2014
Oldest Company Age 16 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Eye Kare Kilitch Limited U24297MH2009PLC198224
Director27 May 20142009Active

Board colleagues of Pradyumna Upendra Pande

Directorship timeline

Open interactive timeline →
Eye Kare Kilitch Limited
Premium access

Shareholding and investment profile for Pradyumna Upendra Pande

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Pradyumna Upendra Pande

Pradyumna Upendra Pande currently holds 1 directorship: Eye Kare Kilitch Limited (Director, since 27 May 2014).

Pradyumna Upendra Pande was first appointed on 27 May 2014 as Director at Eye Kare Kilitch Limited.

The current boards of Pradyumna Upendra Pande's companies include Divya Paresh Mehta (Eye Kare Kilitch Limited), Mukesh Damji Shah (Eye Kare Kilitch Limited), Mukesh Manmohandas Agashiwala (Eye Kare Kilitch Limited), Neha Paresh Mehta (Eye Kare Kilitch Limited), Paresh Prataprai Mehta (Eye Kare Kilitch Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available